YU, QINGPING – Trademark Portfolio

Entity Type: 01

YU, QINGPING holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include TOHKE and DICRIS. The owner is based in LINYI.

NO. 347, HOUBASHAN VILLAGE, XUJIAHU TOWN

YISHUI COUNTY

LINYI 276400 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DICRIS
DICRIS
Pending 2025
TOHKE
TOHKE
Registered 2024
DICRIS
DICRIS
Registered 2024

Trademark Classifications

YU, QINGPING's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does YU, QINGPING have?

YU, QINGPING has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does YU, QINGPING file in?

YU, QINGPING files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are YU, QINGPING's most well-known trademarks?

YU, QINGPING's registered trademark portfolio includes well-known marks such as TOHKE and DICRIS. These are among 2 currently registered trademarks in the portfolio.

What is YU, QINGPING's trademark registration success rate?

YU, QINGPING has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.